A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.

Bao Y, Yang S, Ding Y, Zhou J, Zheng X, Chen R, Jiang Z, Meng N, Pan D, Lu J, Guan J, Ye J, Zhu H, Xu N, Xie C, Yu L, Lu L, Lu W

Open source

DOI
10.1016/j.ajps.2026.101175
Published
2026 Aug
Container
Asian journal of pharmaceutical sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ajps.2026.101175,
  title = {A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.},
  author = {Bao Y and Yang S and Ding Y and Zhou J and Zheng X and Chen R and Jiang Z and Meng N and Pan D and Lu J and Guan J and Ye J and Zhu H and Xu N and Xie C and Yu L and Lu L and Lu W},
  year = {2026},
  journal = {Asian journal of pharmaceutical sciences},
  doi = {10.1016/j.ajps.2026.101175},
  url = {https://doi.org/10.1016/j.ajps.2026.101175}
}

RIS

TY  - JOUR
TI  - A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.
AU  - Bao Y
AU  - Yang S
AU  - Ding Y
AU  - Zhou J
AU  - Zheng X
AU  - Chen R
AU  - Jiang Z
AU  - Meng N
AU  - Pan D
AU  - Lu J
AU  - Guan J
AU  - Ye J
AU  - Zhu H
AU  - Xu N
AU  - Xie C
AU  - Yu L
AU  - Lu L
AU  - Lu W
PY  - 2026
JO  - Asian journal of pharmaceutical sciences
DO  - 10.1016/j.ajps.2026.101175
UR  - https://doi.org/10.1016/j.ajps.2026.101175
ER  - 

APA

Y, B., S, Y., Y, D., J, Z., X, Z., R, C., Z, J., N, M., D, P., J, L., J, G., J, Y., H, Z., N, X., C, X., L, Y., L, L., & W, L. (2026). A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.. Asian journal of pharmaceutical sciences. https://doi.org/10.1016/j.ajps.2026.101175

Source records